2450 Holcombe Blvd, Houston, TX 77021, USA

Vyripharm is committed

Vyripharm is committed to innovations helping people live better lives.  Learn more about Novel Integrated Theranostic Approach for the Treatment of Viral Infections like COVID-19 press release

Read the Press Release

Theranostic products for Personalized Medicine

"Personalized Medicine"- providing patients with the right drug, at the right dose, at the right time

Translational Research directed towards Drug Discovery and Development

Drug processing and development from "bench to bedside"

Comprehensive Regulatory Traditional and Non-traditional Drug Testing

Maintaining GLP/GMP regulatory standards for synthetic pharmaceuticals and natural pharmaceuticals (botanicals)

Quality Assurance and Quality Control

QA/QC is Vyripharm's focus for enhancing public safety, public health and public awareness

Development of Drug Delivery Systems

To deliver a drug dose in the right amount at the right time and with better efficacy

Data Storage, Data Monitoring

QC data with IT integration

Translational Research

Targeted treatment of debilitating diseases such PTSD. Vyripharm’s translational research platform targets chronic disease states.

Novel Drug Development

Pharmaceuticals and Radiopharmaceuticals. Vyripharm develops novel platforms for molecular imaging and therapy.

Products to fight Chronic Disease States

Chronic Pain. Vyripharm’s translational drug delivery platforms should reduce the 1.5 billion people suffering with chronic pain worldwide.